Technical Analysis for EQ - Equillium, Inc.

Grade Last Price % Change Price Change
grade F 6.04 -12.46% -0.86
EQ closed down 12.46 percent on Wednesday, February 20, 2019, on 67 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Earnings due: Feb 21

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Down Down
See historical EQ trend table...

Date Alert Name Type % Chg
Feb 20 New 52 Week Closing Low Bearish 0.00%
Feb 20 180 Bearish Setup Bearish Swing Setup 0.00%
Feb 20 Wide Bands Range Expansion 0.00%
Feb 20 Oversold Stochastic Weakness 0.00%
Feb 19 NR7 Range Contraction -12.46%
Feb 19 Wide Bands Range Expansion -12.46%
Feb 19 Oversold Stochastic Weakness -12.46%
Feb 15 Wide Bands Range Expansion -7.22%
Feb 15 Down 3 Days in a Row Weakness -7.22%
Feb 15 Oversold Stochastic Weakness -7.22%

Older signals for EQ ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Equillium is a biotechnology company leveraging deep understanding of immunobiology to develop products to treat severe autoimmune and inflammatory disorders with high unmet medical need. Equillium’s initial product candidate, EQ001 (itolizumab), is a clinical-stage, first-in-class monocolonal antibody that selectively targets the novel immune checkpoint receptor CD6 and is designed to modulate T cells that drive immuno-inflammation. Itolizumab is a clinically-validated therapeutic with a favorable safety and tolerability profile. Equillium plans to advance EQ001 into clinical development in multiple indications of high unmet medical need and believes EQ001 has the potential to be a best-in-class disease modifying therapeutic.
Medicine Biotechnology Health Immunology Immune System Antibody Monoclonal Antibody Autoimmunity Sutro Biopharma Glycoproteins
Is EQ a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 19.69
52 Week Low 5.5
Average Volume 46,440
200-Day Moving Average 0.0
50-Day Moving Average 9.4647
20-Day Moving Average 8.1875
10-Day Moving Average 7.187
Average True Range 1.0409
ADX 15.48
+DI 15.0184
-DI 26.3903
Chandelier Exit (Long, 3 ATRs ) 10.1973
Chandelier Exit (Short, 3 ATRs ) 9.0327
Upper Bollinger Band 10.7653
Lower Bollinger Band 5.6097
Percent B (%b) 0.08
BandWidth 62.96916
MACD Line -1.0103
MACD Signal Line -0.8624
MACD Histogram -0.1479
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.36
Resistance 3 (R3) 7.50 7.21 7.14
Resistance 2 (R2) 7.21 6.87 7.14 7.07
Resistance 1 (R1) 6.62 6.66 6.48 6.48 6.99
Pivot Point 6.33 6.33 6.25 6.26 6.33
Support 1 (S1) 5.74 5.99 5.60 5.60 5.09
Support 2 (S2) 5.45 5.78 5.38 5.01
Support 3 (S3) 4.86 5.45 4.94
Support 4 (S4) 4.72